Results 1 to 10 of about 195 (85)
IgG4-related disease presenting with combined pulmonary fibrosis and emphysema (CPFE)
Respiratory Medicine Case Reports, 2018 A 64-year-old man was admitted to our hospital with an abnormal chest shadow. The patient was a current-smoker and had a past illness of autoimmune pancreatitis with a high serum level of IgG4, 348 mg/dL.
Takafumi Suda +2 more
exaly +3 more sources
Combined Pulmonary Fibrosis and Emphysema: A Case Report and Literature Review [PDF]
Journal of Cardio-Thoracic Medicine, 2021 The syndrome of combined emphysema of the upper lobes and fibrosis of the lower lobes on chest computed tomography results in a characteristic functional profile, with preserved lung volumes, hypoxemia at exercise.
Shaghayegh Badriahmadi +1 more
doaj +1 more source
Arthritis Research & Therapy, 2021 Background This study aimed to analyze the literature systematically to determine the clinical characteristics and prognosis of patients with connective tissue disease (CTD) with combined pulmonary fibrosis and emphysema (CPFE) compared to those of ...
Bon San Koo +6 more
doaj +1 more source
The impact of emphysema in pulmonary fibrosis [PDF]
European Respiratory Review, 2013 Several groups have described a syndrome in which idiopathic pulmonary fibrosis (IPF) coexists with pulmonary emphysema. This comes as no surprise since both diseases are associated with a history of exposure to cigarette smoke.
Vincent Cottin
doaj +1 more source
Therapeutic Advances in Respiratory Disease, 2021 Background: Lung cancer is an important complication of combined pulmonary fibrosis and emphysema (CPFE). Whether the risk of lung cancer is higher in CPFE patients with usual interstitial pneumonia (UIP) than those with idiopathic pulmonary fibrosis ...
Qianqian Chen +4 more
doaj +1 more source
Chronic Obstructive Pulmonary Disease Combined with Interstitial Lung Disease [PDF]
Tuberculosis and Respiratory Diseases, 2022 Although chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) have distinct clinical features, both diseases may coexist in a patient because they share similar risk factors such as smoking, male sex, and old age.
Joon Young Choi +2 more
doaj +1 more source
Acute exacerbations of COPD versus IPF in patients with combined pulmonary fibrosis and emphysema
Respiratory Research, 2020 Rationale Patients with combined pulmonary fibrosis and emphysema (CPFE) may develop acute exacerbations of IPF (AE-IPF) or COPD (AE-COPD). The incidence and the characteristics of exacerbations in patients with CPFE (e.g., COPD vs IPF) have not been ...
Massa Zantah +5 more
doaj +1 more source
BMC Pulmonary Medicine, 2023 Background and aim Pulmonary hypertension (PH) is a common complication of combined pulmonary fibrosis and emphysema (CPFE). Whether the incidence of PH is increased in CPFE compared with pure pulmonary fibrosis or emphysema remains unclear.
Hangqi Ni +3 more
doaj +1 more source
Development of a nomogram for predicting the presence of combined pulmonary fibrosis and emphysema
BMC Pulmonary Medicine, 2021 Background In the clinical management of patients with combined pulmonary fibrosis and emphysema (CPFE), early recognition and appropriate treatment is essential.
Xueting Yuan, Jin Jin, Xiaomao Xu
doaj +1 more source
Annals of Medical Science and Research, 2023 Tobacco smoke exposure causes diverse pulmonary manifestations with involvement of alveolar, interstitial, and vascular diseases due to inflammatory pathology apart from more lethal lung cancer. Combined pulmonary fibrosis and emphysema is a heterogenous
Shital Patil, Gajanan Gondhali
doaj +1 more source